Ledger.Open graph →
SEC Form D · filed November 30, 2021

Vita Therapeutics, Inc

Offering
$12.0M
Sold
$12.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BALTIMORE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (13)

Douglas Falk · Baltimore, MDExec · DirectorPat Lavecchia · Baltimore, MDDirectorVlad Coric · Baltimore, MDDirectorJames Peyer · NOVATO, CADirectorPaul G. Smith · Toronto, Ontario, CanadaExec · DirectorJohn Eckert · Toronto, Ontario, CanadaDirectorStephen Taylor · Toronto, Ontario, CanadaDirectorFaizzan Ahmad · Baltimore, MDDirectorDaniel Herz · Philadelphia, PAExec · DirectorAlan Marshall · St. George's, BermudaDirectorAnthony R. Puckett · Tempe, AZDirectorJames Peyer · NOVATO, CADirectorFaizzan Ahmad · Baltimore, MDDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗